SUPN Dividend History & Analysis | N/A Yield

SUPN has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of February 2026, Supernus Pharmaceuticals (SUPN) does not pay a dividend.

Top Dividend Payers in Pharmaceuticals

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap USD Dividend Yield TTM Yield on Cost 5y
SIGA 480 M 10.4% 12.2%
GS71 102,926 M 4.22% 7.28%
BMY 113,778 M 4.98% 5.04%
SAN 113,221 M 4.30% 5.91%
SNY 114,158 M 4.43% 5.55%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap USD Growth Rate Consistency
ZTS 54,250 M 18.9% 100%
VIRP 3,475 M 17.9% 82.1%
LLY 918,097 M 15.3% 99.5%
BMY 113,778 M 14.0% 92.6%
MRK 64,417 M 12.0% 91.8%

Quality Dividend Peers in Pharmaceuticals

BMY
Bristol-Myers Squibb
 4.98% Yield
MRK
Merck
 3.70% Yield
JNJ
Johnson & Johnson
 3.02% Yield
NVS
Novartis
 3.68% Yield
IPN
Ipsen
 1.34% Yield
ZEG
AstraZeneca
 2.08% Yield

SUPN Dividend History: as of February 2026

No dividends paid yet.

SUPN Dividend FAQ

Supernus Pharmaceuticals (NASDAQ: SUPN) is a U.S.-focused biopharma that builds a niche portfolio of CNS-targeted therapies, commercializing products such as Qelbree (non-stimulant ADHD), GOCOVRI (levodopa/carbidopa for Parkinson’s dyskinesia), Oxtellar XR (extended-release oxcarbazepine for partial-onset seizures), and APOKYN (off-episode treatment for advanced Parkinson’s disease). The company also markets specialty products-including Trokendi XR (topiramate for epilepsy and migraine prophylaxis), XADAGO (levodopa/carbidopa for Parkinson’s off episodes), and MYOBLOC (botulinum toxin for cervical dystonia and chronic sialorrhea)-through wholesalers, specialty pharmacies, and distributors.

What is the Dividend Yield of SUPN?

As of February 2026, SUPN`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 51.65.

Does SUPN pay a dividend?

As of February 2026 SUPN does not pay a dividend.

How often does SUPN pay dividends?

Over the last 12 months, SUPN has issued dividend payments.

SUPN dividend forecast

Based on historical data, the forecasted dividends per share for SUPN for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).
This suggests the dividend will remain relatively stable.

Will SUPN pay dividends in 2026?

The next Ex-Dividend date for Supernus Pharmaceuticals (SUPN) is currently unknown.

What is the next Ex-Dividend Date for SUPN?

The next Ex-Dividend date for Supernus Pharmaceuticals (SUPN) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of SUPN?

SUPN's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of SUPN?

SUPN's 5-Year Yield on Cost is -%. If you bought SUPN's shares at 30.71 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of SUPN?

SUPN Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does SUPN have a good Dividend Yield?

SUPN`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of SUPN?

The Dividend Payout Ratio of SUPN is unknown.

What is the Dividend Rating of SUPN?

SUPN`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

SUPN Outstanding Shares Analysis

What is the Trend in SUPN's Outstanding Shares?

Supernus Pharmaceuticals's outstanding shares have increased by approximately 1.35% annually over the past 3 years (Trend Reliability: 100.0%).

Neutral: Share count is relatively stable with minor dilution. This has minimal impact on dividend per share calculations.

Has SUPN ever had a Stock Split?

No stock splits on record. The share count changes shown above reflect buybacks, new issuance, or employee compensation rather than structural splits.

Year Number of Shares Annual Growth Rate
2009 13,855,300
2010 13,855,300
2011 13,855,300
2012 26,626,900 +92.18%
2013 34,647,800 +30.12%
2014 43,201,200 +24.69%
2015 49,598,000 +14.81%
2016 51,974,400 +4.79%
2017 53,534,200 +3%
2018 54,104,000 +1.06%
2019 53,649,100 -0.84%
2020 53,747,100 +0.18%
2021 53,256,100 -0.91%
2022 62,087,700 +16.58%
2023 55,057,900 -11.32%
2024 56,464,800 +2.56%
2025 56,552,700 +0.16%

Key Metric Definitions

Dividend Yield
Annual dividend per share divided by current share price.
Payout Ratio
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR)
Compound annual growth rate of dividends over the last 5 years.
Consistency
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating
Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-02-03 04:22